Journal of Drugs in Dermatology

Acne News with Dr. Adam Friedman
acneStraight from the desk of ODAC Medical Director, Dr. Adam Friedman, we share what’s popping in acne (spoiler alert: quite a lot!). According to Dr. Friedman, the innovation drought is over! Watch as he reviews all new topical and oral therapeutics (some of which are completely new active agents) and while at it, shares and debunks important information related to the management of acne vulgaris …
acne
Lessons from the Skin Microbiome: Innate Immunity, Skin Disease, and COVID-19
skin microbiomeWhile I was beginning the process of “scrubbing in” to assist in the hemicolectomy case as an intern, I carefully squeezed the anti-septic chlorhexidine-soaked sponge and watched the brown solution drip its way down my forearms. I continued the ritual by cleaning under the fingernails and on every plane of the fingers, hands, and forearms multiple times. After all; “Clean Hands Save Lives,� …
skin microbiome
Easing the Management of Atopic Dermatitis
Atopic DermatitisDr. Friedman, jack of many trades, Professor and Interim Chair of Dermatology at George Washington University provided an excellent overview of ways to achieve victory over atopic dermatitis (AD). This expert discussion took place during the ODAC Inflammatory Diseases Symposium on December 3, 2020. How could we possibly cover atopic dermatitis in 20 minutes? Well, Dr. Friedman skillfully led us …
Atopic Dermatitis
JDD February 2021 Issue Highlights: From Acne and Depression to “Inflammaging”
AcneThe February issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from acne and depression to "Inflammaging. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Efforts are needed to implement a clinically useful definition of moderate plaque psoriasis in Dermatologists’ Perspectives on Defining Moderate Ps …
Acne
5-Fluorouracil Therapeutic Cheat Sheet
FluoroplexActinic keratoses represent the most common dermatologic diagnosis in patients older than 45 years old in the United States and account for 5.2 million visits annually.1 Cutaneous field cancerization represents areas with a high burden of both clinical and subclinical actinic damage. Cryotherapy can often be combined with topical chemotherapy for a synergistic approach. We continue our series, The …
Fluoroplex